1345 exoASO-C/EBPβ™: An engineered exosome therapeutic that selectively targets MDSCs and induces potent single-agent anti-tumor activity in checkpoint refractory tumor models

Authors :: Sushrut Kamerkar
Charan Leng
Olga Burenkova
Su Chul Jang
Kelvin Zhang
Samuel Kasera
Tong Zi
Sanah Langer
Silvia Siso
Timothy Soos
Dalia Burzyn
Sriram Sathyanaryanan
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools